HapAプロテアゼは,ERKシグナル伝達を調節し,がん細胞の生存能力を低下させるため,PAR-1/2を標的とする
David Tena-Chaves1, Inês Pontes-Gomes1, José Ángel Palomeque1
1Centro de Investigación del Cáncer, CSIC and Universidad de Salamanca, Salamanca, Spain.
Cell death discovery
|August 28, 2025
まとめ
ビブリオ・コレラ
科学分野:
- 微生物学
- 細胞生物学
- 癌 研究
背景:
- Vibrio choleraeの毒性因子は宿主細胞の生存能力に影響しますが,がん細胞への影響は不明です.
- がん細胞に影響を与える細菌の成分とメカニズムはほとんど不明です.
- 癌細胞に分泌されるタンパク質が欠けているV. cholerae変異体の調査.
研究 の 目的:
- 癌細胞にV.コレラが分泌するタンパク質の影響を調査する.
- ガン細胞の生存に影響を与える細菌の要因を特定する.
- 癌治療の潜在的治療目標を探求する
主な方法:
- タンパク質を分泌しないV.コレラ変異体の研究
- 癌細胞に対する細菌成分の影響を分析した.
- プロテアゼ活性化受容体 (PAR) と下流信号伝達経路の分裂を調査した.
主要な成果:
- 癌細胞の生存率を低下させる重要な要因として,ヘマグルチニン亜金属タンパク質酶 (HapA) を特定した.
- HapAは,上皮がん細胞のプロテアゼ活性化受容体1と2 (PAR-1/ 2) を裂く.
- HapA媒介の分裂は一時的にMEKとERKキナーゼを活性化し,カスパース7とアポトーシスを開始します.
結論:
- HapAは,がん細胞の生存能力に影響を与える重要な毒性因子です.
- HapAは人間のPAR-1/2を標的とし,MEK-ERKの信号を調節する.
- PAR-1/2の選択的なHapA分裂は,新しい抗がん療法の可能性を提示しています.
関連する概念動画
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K


